Value-based pricing is a convenient and effective pricing strategy for B2B SaaS companies that CEOs and pricing managers ...

This article was originally published on Apparelist. Money left on the table doesn’t pay bills. Every day, print shops across the country calculate their costs, add a markup, and hand over quotes that ...

Pricing is a powerful tool. Used well, it reinforces value, discipline and strategic clarity. Used as a crutch, it delays ...

It is hard to read a newspaper these days without coming across a story about the high and ever increasing cost of drugs. The Wall Street Journal named drug prices the top health story of 2015.

Traditional billing models like hourly and fixed-fee billing often fall short of delivering true value to clients. Misaligned incentives, lack of transparency, and a disregard for the actual value ...

Value-based pricing aligns prescription drug prices to their clinical benefits, leading to lower spending and better health outcomes. In the United States, pharmaceutical companies are able to set the ...

Over the past 40 years, we’ve read many things about value-based pricing and the benefits it can bring to the bottom line. Pricing scholars, consultants, and experts highly recommend value-based ...

The changing landscape of drug pricing policy in the U.S. has implications for the global pace and direction of innovation. Drug policy changes are being influenced by perceptions of the value of ...

More accounting firms than ever are branching out, expanding beyond traditional tax and compliance services into things like advisory services to meet the expanding expectations of their clients and ...

Well-functioning markets for branded prescription drugs or biologics reward innovative products that are valuable to patients and their families while penalizing those that are not. Well-functioning ...

Wendy’s/Arby’s Group Inc. said it would focus both its quick-service chains on value pricing this fall, including 99-cent Frosty treats and a new menu at Arby’s featuring 30 items for less than $3.

I reiterate a Sell rating on Ecolab Inc. due to ongoing weak demand in heavy industrial and paper markets despite management's effective margin expansion strategies. Q2 FY 2025 results showed modest 3 ...